stoxline Quote Chart Rank Option Currency Glossary
  
Scienture Holdings, Inc. (SCNX)
0.6282  0.018 (2.98%)    12-08 15:37
Open: 0.6244
High: 0.6639
Volume: 1,137,687
  
Pre. Close: 0.61
Low: 0.61
Market Cap: 10(M)
Technical analysis
2025-12-08 3:20:53 PM
Short term     
Mid term     
Targets 6-month :  1.02 1-year :  1.29
Resists First :  0.87 Second :  1.11
Pivot price 0.58
Supports First :  0.5 Second :  0.41
MAs MA(5) :  0.6 MA(20) :  0.61
MA(100) :  1.07 MA(250) :  0
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  63.3 D(3) :  49.3
RSI RSI(14): 47.3
52-week High :  6.4 Low :  0.46
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ SCNX ] has closed below upper band by 15.1%. Bollinger Bands are 86.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.64 - 0.64 0.64 - 0.65
Low: 0.58 - 0.58 0.58 - 0.58
Close: 0.6 - 0.61 0.61 - 0.61
Company Description

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Headline News

Fri, 05 Dec 2025
Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Fri, 14 Nov 2025
Scienture Holdings stockholders approve reverse split and equity plan expansion - Investing.com

Thu, 13 Nov 2025
Scienture Holdings Expands Equity Distribution Agreement - TipRanks

Thu, 13 Nov 2025
Scienture (NASDAQ: SCNX) launches Arbli, FDA-approved liquid losartan; revenue hits $590K - Stock Titan

Thu, 13 Nov 2025
EXCLUSIVE: Scienture Delivers Q3 Revenue Jump With Arbli Sales And Debt Reduction - Yahoo Finance

Wed, 12 Nov 2025
Scienture Holdings, Inc. SEC 10-Q Report - TradingView

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 41 (M)
Shares Float 34 (M)
Held by Insiders 16.8 (%)
Held by Institutions 4.1 (%)
Shares Short 3,400 (K)
Shares Short P.Month 291 (K)
Stock Financials
EPS 0.75
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.56
Profit Margin 0 %
Operating Margin -739.2 %
Return on Assets (ttm) -10.9 %
Return on Equity (ttm) -24.1 %
Qtrly Rev. Growth 809.7 %
Gross Profit (p.s.) 0.01
Sales Per Share 0.01
EBITDA (p.s.) -0.43
Qtrly Earnings Growth 0 %
Operating Cash Flow -11 (M)
Levered Free Cash Flow 2 (M)
Stock Valuations
PE Ratio 0.83
PEG Ratio 0
Price to Book value 0.17
Price to Sales 39.02
Price to Cash Flow -2.3
Stock Dividends
Dividend 1.5
Forward Dividend 0
Dividend Yield 239%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android